Cargando…

Raised circulating tenascin-C in rheumatoid arthritis

INTRODUCTION: The aim of this study was to examine whether circulating levels of the pro-inflammatory glycoprotein tenascin-C (TNC) are elevated in musculoskeletal disorders including rheumatoid arthritis (RA) and to assess in RA whether levels are related to clinical disease status and/or patient r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Page, Theresa H, Charles, Peter J, Piccinini, Anna M, Nicolaidou, Vicky, Taylor, Peter C, Midwood, Kim S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674624/ https://www.ncbi.nlm.nih.gov/pubmed/23193984 http://dx.doi.org/10.1186/ar4105

Ejemplares similares

Detection of antibodies to citrullinated tenascin-C in patients with early synovitis is associated with the development of rheumatoid arthritis
por: Raza, Karim, et al.
Publicado: (2016)

Shared recognition of citrullinated tenascin-C peptides by T and B cells in rheumatoid arthritis
por: Song, Jing, et al.
Publicado: (2021)

Endogenous Control of Immunity against Infection: Tenascin-C Regulates TLR4-Mediated Inflammation via MicroRNA-155
por: Piccinini, Anna M., et al.
Publicado: (2012)

Tenascin-C in Osteoarthritis and Rheumatoid Arthritis
por: Hasegawa, Masahiro, et al.
Publicado: (2020)

Tenascin-C: Form versus function
por: Giblin, Sean P, et al.
Publicado: (2014)

Advances in tenascin-C biology
por: Midwood, Kim S., et al.
Publicado: (2011)

The role of tenascin-C in tissue injury and tumorigenesis
por: Midwood, Kim S., et al.
Publicado: (2009)

Tenascin-C Suppresses Rho Activation
por: Wenk, Melissa B., et al.
Publicado: (2000)

Identification of an immunodominant peptide from citrullinated tenascin-C as a major target for autoantibodies in rheumatoid arthritis
por: Schwenzer, Anja, et al.
Publicado: (2016)

Tenascin-C: Exploitation and collateral damage in cancer management
por: Spenlé, Caroline, et al.
Publicado: (2015)

Editorial: Tenascins – Key Players in Tissue Homeostasis and Defense
por: Yoshida, Kyoko Imanaka, et al.
Publicado: (2022)

Mapping tenascin-C interaction with toll-like receptor 4 reveals a new subset of endogenous inflammatory triggers
por: Zuliani-Alvarez, Lorena, et al.
Publicado: (2017)

Tenascin-C is a driver of inflammation in the DSS model of colitis
por: Ozanne, James, et al.
Publicado: (2022)

Biased TCR gene usage in citrullinated Tenascin C specific T-cells in rheumatoid arthritis
por: Sharma, Ravi K., et al.
Publicado: (2021)

Chemokine Binding to Tenascin-C Influences Chemokine-Induced Immune Cell Migration
por: Domaingo, Alissa, et al.
Publicado: (2023)

The distribution of tenascin-X is distinct and often reciprocal to that of tenascin-C
Publicado: (1994)

Airway Epithelial Cells Generate Pro-inflammatory Tenascin-C and Small Extracellular Vesicles in Response to TLR3 Stimuli and Rhinovirus Infection
por: Mills, Jake T., et al.
Publicado: (2019)

Investigating Chemokine-Matrix Networks in Breast Cancer: Tenascin-C Sets the Tone for CCL2
por: Gschwandtner, Martha, et al.
Publicado: (2023)

Tenascin-C and integrins in cancer
por: Yoshida, Toshimichi, et al.
Publicado: (2015)

Immunosuppression via Tenascin-C
por: Bellone, Matteo, et al.
Publicado: (2015)

Tenascin C in Lung Diseases
por: Donovan, Chantal, et al.
Publicado: (2023)

Invasion of Melanoma in Double Knockout Mice Lacking Tenascin‐X and Tenascin‐C
por: Matsumoto, Ken‐ichi, et al.
Publicado: (2002)

Tenascin‐C immobilizes infiltrating T lymphocytes through CXCL12 promoting breast cancer progression
por: Murdamoothoo, Devadarssen, et al.
Publicado: (2021)

Serendipity; Close Encounter of Tenascin C
por: Sakakura, Teruyo
Publicado: (2021)

Advances on the roles of tenascin-C in cancer
por: Yilmaz, Alev, et al.
Publicado: (2022)

Tenascin-W is a better cancer biomarker than tenascin-C for most human solid tumors
por: Brellier, Florence, et al.
Publicado: (2012)

Characterization of tenascin-C as a novel biomarker for asthma: utility of tenascin-C in combination with periostin or immunoglobulin E
por: Yasuda, Mina, et al.
Publicado: (2018)

Tenascin-C drives persistence of organ fibrosis
por: Bhattacharyya, Swati, et al.
Publicado: (2016)

Tenascin-C: Friend or Foe in Lung Aging?
por: Gremlich, Sandrine, et al.
Publicado: (2021)

Tenascin-C in Heart Diseases—The Role of Inflammation
por: Imanaka-Yoshida, Kyoko
Publicado: (2021)

Tenascin-C: an emerging prognostic biomarker in diabetes
por: Yonebayashi, Saori, et al.
Publicado: (2020)

Circulating immune complexes contain citrullinated fibrinogen in rheumatoid arthritis
por: Zhao, Xiaoyan, et al.
Publicado: (2008)

Potent anti-inflammatory effects of the narrow spectrum kinase inhibitor RV1088 on rheumatoid arthritis synovial membrane cells
por: To, Wing S, et al.
Publicado: (2015)

Expression and degeneration of tenascin-C in human lung cancers.
por: Kusagawa, H., et al.
Publicado: (1998)

Spatial organization of the tenascin-C microenvironment in experimental and human cancer
por: Spenlé, Caroline, et al.
Publicado: (2015)

Tenascin turns on the EGFR
por: Jegalian, Karin
Publicado: (2001)

The evolution of tenascins and fibronectin
por: Adams, Josephine C, et al.
Publicado: (2015)

Tenascin-C and mechanotransduction in the development and diseases of cardiovascular system
por: Imanaka-Yoshida, Kyoko, et al.
Publicado: (2014)

Tenascin-C in aneurysmal subarachnoid hemorrhage: deleterious or protective?
por: Suzuki, Hidenori, et al.
Publicado: (2016)

Tumor-penetrating peptide for systemic targeting of Tenascin-C
por: Lingasamy, Prakash, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3ph6inpo70b2q9ei7ts87gbj8a